Sally Watson

Doctor of Medicine,  Toronto General - University Health Network 

Location: United States

Consulting Services

IT-Web-Mobile Technology Pharma-CRO-Device Legal Support Research Consulting Sales and Marketing

Areas Of Interest

Contraction, Isometric Cranial Epidural Hematomas Folic Acid, (DL)-Isomer Agents, Bronchial-Constricting Alper Disease Spalax Ablation, Laser Tissue Far-Western Blots Heparin, Sodium Heavy Chain Diseases Private Sector Classical Pathway C3 Convertase Agraphias, Constructional Broncholysin PMS-Gabapentin Normison Pressure, Atrial Berries Heart Diseases, Coronary Transcranial Magnetic Stimulation, Single Pulse soliums, Taenia Ischemic Optic Neuropathies Protein, Wnt3 Archamoebae Vaccine, Oral Poliovirus Methyltransferase, Protein-L-Isoaspartate Deposul Mastitis, Granulomatous

Professional Narrative

Dr. Sally Watson was born in DuBois, Pennsylvania and is a graduate of Villanova University. He obtained his medical degree at Thomas Jefferson University in Philadelphia. His residency was at Thomas Jefferson and its affiliated Wills Eye Hospital, and he completed his training with fellowships at the University of Connecticut incataract andcorneal surgery.

Dr. Watson has thirty years’ experience in ophthalmic surgery,withspecialinterestin cataract surgery,corneal transplantation,andlaserrefractiveprocedures.Heisa founding member of Precision LASIK Group, Chief of Ophthalmology at The Hospital ofCentral Connecticut,andco-medical director of the Connecticut eye bank.

Employment

Medical Writer, Harvard Med 1997
Medical Writer, Amgen 2013

Education

Doctor of medicine, Harvard Medical School 2003
Director Medicine, Weill Medical College 1993

Referees

Publications

Hou X, Zaks T, Langer R, Dong Y. Lipid nanoparticles for mRNA delivery. Nat Rev Mater. 2021;6(12):1078-1094. doi: 10.1038/s41578-021-00358-0. Epub 2021 Aug 10. PMID: 34394960; PMCID: PMC8353930.

Oberli MA, Reichmuth AM, Dorkin JR, Mitchell MJ, Fenton OS, Jaklenec A, Anderson DG, Langer R, Blankschtein D. Lipid Nanoparticle Assisted mRNA Delivery for Potent Cancer Immunotherapy. Nano Lett. 2017 Mar 8;17(3):1326-1335. doi: 10.1021/acs.nanolett.6b03329. Epub 2016 Dec 5. PMID: 28273716; PMCID: PMC5523404.

Roberts TC, Langer R, Wood MJA. Advances in oligonucleotide drug delivery. Nat Rev Drug Discov. 2020 Oct;19(10):673-694. doi: 10.1038/s41573-020-0075-7. Epub 2020 Aug 11. PMID: 32782413; PMCID: PMC7419031.

Gupta A, Andresen JL, Manan RS, Langer R. Nucleic acid delivery for therapeutic applications. Adv Drug Deliv Rev. 2021 Nov;178:113834. doi: 10.1016/j.addr.2021.113834. Epub 2021 Sep 4. PMID: 34492233.

Grants,Awards and Certifications

Grants :

No Grants Mentioned !!

Awards & Prizes :

Languages

Language Proficiency :

Translation Services :

Serving Millions of physicians and biomedical scientists in Industry and academia.

Site
Services
Follow Us
Contact Us
  • support@scienceandminds.com

Copyright © 2025 Trialect Inc. All rights reserved. | v2023.06.17.02